Scandion Oncology

Overcoming cancer drug resistance

Navbar
  • About us
    • Executive Management
    • Board of Directors
    • Clinical Advisory Board
  • Research & Development
    • Pipeline
    • Clinical Development
    • Science
      • Cancer drug resistance
      • Technology Platform
      • SCO-101
  • Press releases
  • Investors & Media
    • Share information
    • Financial Reports
      • Annual reports
      • Interim reports
    • Presentations
    • Media
      • Image library
      • Video library
    • Analyst Coverage
    • Prospectuses
      • Rights Issue 2022
      • Rights Issue 2020
      • Rights Issue 2019
      • Subscription Warrant (SCOL TO 1)
      • IPO 2018
    • Corporate governance
    • Events
      • General meetings
      • Financial calendar
  • Contact
    • Career
    • Business development
Skip to content

Presentations

AllInvestor PresentationsScientific Presentations
24 April 2023

Swiss Biotech Day Basel, April 24-25, 2023

Swiss Biotech Day Basel, April 24-25, 2023
30 March 2023

Swiss Nordic Bio Zurich

Swiss Nordic Bio Zurich, March 30, 2023
10 October 2022

DAF visit to Scandion

See the slide deck here.
4 October 2022

Conference call on CORIST

See the presentation or replay the conference call.
16 June 2022

Redeye Transactions

Watch President & CEO Bo Rode Hansen’s presentation from Redeye Transactions
14 June 2022

Aktiespararna

Watch Chief Operating Officer Maj Hedtjärn present Scandion at Aktiespararna Småbolagsdagarna 2022
11 June 2022

DAF Interview

Watch President and CEO Bo Rode Hansen present Scandion to The Danish Shareholder Association
10 June 2022

Investor Call

Watch the presentation from the Investor call on June 10, 2022
8 June 2022

Redeye Growth Day 2022

Watch the interview with President & CEO Bo Rode Hansen and the Company presentation from Redeye Growth Day
1 June 2022

ØU Life Science Investor Konference

Watch President & CEO Bo Rode Hansen’s presentation from ØU Life Science Investor Konference
11 April 2022

Redeye interview (video)

Watch the ”get to know-interview” with President & CEO Bo Rode Hansen from April 11, 2022.
4 April 2022

Aktieinfo Investor Conference

Watch Bo Rode Hansen’s presentation from Aktieinfo on April 4, 2022
  1. Frontpage

About us

  • About us
  • Executive Management
  • Board of Directors
  • Clinical Advisory Board

Research & Development

  • Research & Development
  • Pipeline
  • Clinical Development
  • Science

Investors & Media

  • Investors & Media
  • Share information
  • Financial Reports
  • Presentations
  • Media
  • Analyst Coverage
  • Prospectuses
  • Corporate governance
  • Events

Contact us

Scandion Oncology A/S
Symbion
Fruebjergvej 3
2100 Copenhagen
Denmark

Phone: +45 38 10 20 17
info@scandiononcology.com

Media and Investor relations:
Email: ir@scandiononcology.com
Phone: +45 29 60 35 32

Follow us


Scandion Oncology - The Cancer Drug Resistance Company

Our vision is to overcome cancer drug resistance in order to improve lives for cancer patients and their families

© Copyright 2022 - Scandion Oncology A/S | We use cookies to improve our services | Disclaimer: Market data could be delayed. Delivered by Cision.